|Chemical and physical data|
|Molar mass||247.25 g/mol g·mol−1|
|3D model (JSmol)|
Racivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV. It is the enantiomer of emtricitabine, a widely used NRTI, meaning that the two compounds are mirror images of each other.
|This antiinfective drug article is a stub. You can help Wikipedia by expanding it.|